U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: October 6-12, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: October 6-12, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 10/06/2024
Location: Virtual
Subject: American College of Chest Physicians (CHEST) 2024 Annual Meeting; The Drive to Tame Tobacco: Public-Private Steps for a Tobacco-Free Future
FDA Participant/Group: HAIDER WARRAICH;
Non FDA Participant/Group: Industry, academia, and media

Event Date: 10/07/2024
Location: Virtual
Subject: FDA Science Board Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, and other invited attendees

Event Date: 10/07/2024
Location: Virtual
Subject: Kenes' Roundtable of Academia and Industry for Stroke Prevention II (RAISE); Speaker: FDA Approval Process for Drugs and Devices: Progress and Challenges
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, and other invited attendees

Event Date: 10/08/2024
Location: Silver Spring, MD
Subject: Product Development
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members from Breakthrough T1D

Event Date: 10/08/2024
Location: Washington, DC
Subject: The Bestowal of the Decoration of Knight of the Order of Merit of the Italian Republic Upon Dr. Monica Bertagnolli
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, and other invited guests

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 10/07/2024
Location: Virtual
Subject: Reagan Udall Foundation Public Meeting; Opening Remarks: FDA's Final Rule on Requirements for Additional Traceability Records for Certain Foods
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, academia, trade associations, and consumers

Event Date: 10/10/2024
Location: Salt Lake City, UT
Subject: Dietary Supplement Issues of Mutual Interest
FDA Participant/Group: CARA WELCH;
Non FDA Participant/Group: Loren D. Israelsen (United Natural Products Alliance);

Event Date: 10/10/2024
Location: Salt Lake City, UT
Subject: Council for Responsible Nutrition's Convergence Conference; Keynote: FDA's Oversight
FDA Participant/Group: CARA WELCH;
Non FDA Participant/Group: Industry

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Michael Rogers, Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 10/07/2024
Location: Virtual
Subject: FDA Regulatory Meeting
FDA Participant/Group: BROOKE COURTNEY; KELLY NGAN; JACQUELINE CORRIGAN CURAY; HILARY MARSTON;
Non FDA Participant/Group: Cecilia Soriano, Heather Knight, James Borzi, Joseph Schwan, Lynn Pawelski (Baxter);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 10/08/2024
Location: Virtual
Subject: Specialty Care Transformation Summit; Speaker: Anticipating Advances in Cell and Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other registered attendees

Event Date: 10/09/2024
Location: Park City, UT
Subject: a16z Bio + Health BUILD 2024; Panelist: Regulation, Research, and Resilience
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other registered attendees

Event Date: 10/09/2024
Location: Virtual
Subject: FDA NanoDay Symposium 2024 (Hybrid) - A Nanotechnology Task Force Event; Speaker: Application of Nanotechnology: mRNA-Based Therapeutics and Vaccines
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 10/09/2024
Location: Virtual
Subject: 2024 Precision Health Summit - Transforming Patient Outcomes Through Data-Driven Personalization; Panelist: Ensuring Equitable Access to Precision Regenerative Medicine
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 10/10/2024
Location: Virtual
Subject: Mayo Clinic Center for Individualize Medicine - Rochester Grand Rounds; Speaker: Facilitating Advances in Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Official Name: Michelle Tarver, M.D., Ph.D., Acting Director, Center for Devices and Radiological Health

Event Date: 10/10/2024
Location: Silver Spring, MD
Subject: Comprehensive Program Overview
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Joe Sapiente, Andrew Fish, Stephanie Rizk, Harry Kotlarz (Medical Device Innovation Consortium)

Event Date: 10/10/2024
Location: Silver Spring, MD
Subject: Quarterly Strategy Meeting
FDA Participant/Group: MICHELLE TARVER; KELLIE KELM; JEFFREY SHUREN; KEISHA THOMAS;
Non FDA Participant/Group: Todd Brill, Stefan Kaufmann, Boris Shkolnik, Takeshi Ogura, Kimberly Paris (Olympus)

Event Date: 10/10/2024
Location: Silver Spring, MD
Subject: Corporate Safety Strategies
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Steve C. De Baca, Carla Goulart Peron, Lee Evans, Kara Carter (Philips)

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 10/10/2024
Location: Virtual
Subject: Barclays Investment Bank Event; Speaker: Tobacco Regulatory Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of Barclays Investment Bank

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top